Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for PANDAS
NCT01281969Phase 3Completed
- Sponsor
- National Institute of Mental Health
- Start
- Jan 2011
- Primary completion
- Dec 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous human immunoglobulin in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), sponsored by National Institute of Mental Health. Started Jan 2011; status: completed.
02
Drugs
intravenous human immunoglobulin
03
Conditions
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)
Beyond the preview
Go deeper on NCT01281969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281969.